Funding Rounds
PreciseDx August 2024 Series B Funding Round
PreciseDxPreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Summary
Stage: Series B
Raised Amount: $20.70M
Raised Date: 2024-08-22